Relationships between the mitochondrial permeability transition and oxidative stress during ara-C toxicity

Cancer Research

Volumn 57, Issue 12, 1997, Pages 2446-2451

  Backway, Karen L ^a   McCulloch, Ernest A ^b   Chow, Sue ^a   Hedley, David W ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; GLUTATHIONE; PHOSPHATIDYLSERINE;

APOPTOSIS; ARTICLE; BLAST TRANSFORMATION; CALCIUM CELL LEVEL; CELL DEATH; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; TARGET CELL;

CALCIUM; CYTARABINE; FLOW CYTOMETRY; HUMANS; INTRACELLULAR MEMBRANES; LEUKEMIA, MYELOCYTIC, ACUTE; MEMBRANE POTENTIALS; MITOCHONDRIA; OXIDATIVE STRESS; PERMEABILITY; PHOSPHATIDYLSERINES; REACTIVE OXYGEN SPECIES; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0030943967     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Chu, E., and Takimoto, C. H. Antimetabolites. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, pp. 358-370. Philadelphia: J. B. Lippincott Co., 1993.
2. Yang, G. S., Wang, C., Minden, M. D., and McCulloch, E. A. Fluorescence labeling of nicks in DNA from leukemic blast cells as a measure of damage following 1-β-D-arabinofuranosylcytosine: application to the study of regulated drug sensitivity. Leukemia (Baltimore), 8: 2052-2059 1994.
3. Hedley, D. W., and McCulloch, E. A. Generation of reactive oxygen intermediates after treatment of blasts of acute myeloblastic leukemia with 1-β-D-arabinofuranosylcytosine: role of bcl-2. Leukemia (Baltimore), 10: 1143-1149, 1996.
4. Slater, A. F. G., Stefan, C., Nobel, I., van den Dobbelsteen, D. J., and Orrenius, S. Intracellular redox changes during apoptosis. Cell Death and Differ., 3: 57-62, 1996.
5. Kane, D. J., Sarafian, T. A., Anton, R., Hahn, H., Gralla, E. B., Valentine, J. S., Örd, T., and Bredesen, D. E. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science (Washington DC), 262: 1274-1277, 1993.
6. Hockenbery, D. M., Oitval, Z. N., Yin, X., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75: 241-251, 1993.
7. Kroemer, G., Petit, P., Zamzami, N., Vayssiere, J. L., and Mignotte, B. The biochemistry of programmed cell death. FASEB J., 9: 1277-1287, 1995.
8. Zamzami, N., Susin, S. A., Marchetti, P., Hirsch, T., Gomez-Monterrey, I., Castedo, M., and Kroemer, G. Mitochondrial control of apoptosis. J. Exp. Med., 183: 1533-1544, 1996.
9. Susin, S. A., Zamzami, N., Castedo, M., Hirsch, T., Marchetti, P., Macho, A., Daugas, E., Geuskens, M., and Kroemer, G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med., 184: 1331-1341, 1996.
10. Castedo, M., Hirsch, T., Susin, S. A., Zamzami, N., Marchetti, P., Macho, A., and Kroemer, G. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J. Immunol., 157: 512-521, 1996.
11. 2+ depletion prevents anoxic death of hepatocytes by inhibiting mitochondrial permeability transition. Am. J. Physiol., 268: C676-C685, 1995.
12. Hoek, J. B., Farber, J. L., Thomas, A. P., and Wang, X. Calcium ion-dependent signalling and mitochondrial dysfunction: mitochondrial calcium uptake during hormonal stimulation in intact liver cells and its implication for the mitochondrial permeability transition. Biochim. Biophys. Acta. 1271: 93-102, 1995.
13. Costantini, P., Chernyak, B. V., Petronilli, V., and Bernardi, P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem., 271: 6746-6751, 1996.
14. Kristal, B. S., Park, B. K., and Yu, B. P. 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J. Biol. Chem., 271: 6033-6038, 1996.
15. Petronilli, V., Costantini, P., Scorrano, L., Colonna, R., Passamonti, S., and Bernardi, P. The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols: increase of the gating potential by oxidants and its reversal by reducing agents. J. Biol. Chem., 269: 16638-16642, 1994.
16. Vayssiere, J. L., Petit, P. X., Risler, Y., and Mignotte, B. Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. Proc. Natl. Acad. Sci. USA, 91: 11752-11756, 1994.
17. Macho, A., Castedo, M., Marchetti, P., Aguilar, J. J., Decaudin, D., Zamzami, N., Girard, P. M., Uriel, J., and Kroemer, G. Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers. Blood, 86: 2481-2487, 1995.
18. Koopman, G., Reutelingsperger, C. P. M., Kuijten, G. A. M., Keehnen, R. M. J., Pals, S. T., and van Oers, M. H. J. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood, 84: 1415-1420, 1994.
19. Martin, S. J., Reutelingsperger, C. P. M., McGahon, A. J., Rader, J. A., van Schie, R. C. A. A., LaFace, D. M., and Green, D. R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med., 182: 1545-1556, 1995.
20. Verhoven, B., Schlegel, R. A., and Williamson, P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J. Exp. Med., 182: 1597-1601, 1995.
21. Hedley, D. W., and Chow, S. Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry, 15: 349-358, 1994.
22. Chow, S., and Hedley, D. W. Flow cytometric determination of glutathione in clinical samples. Cytometry, 21: 68-71, 1995.
23. 2 in the oxidative stress-induced dissipation of the mitochondrial membrane potential. Studies in isolated proximal tubular cells using the nephrotoxin 1,2-dichlorovinyl-L-cysteine. J. Biol. Chem., 269: 14546-14552, 1994.
24. Pastorino, J. G., Simbula, G., Gilfor, E., Hoek, J. B., and Farber, J. L. Protoporphyrin IX, an endogenous ligand of the peripheral benzodiazepine receptor, potentiates induction of the mitochondrial permeability transition and the killing of cultured hepatocytes by rotenone. J. Biol. Chem., 269: 31041-31046, 1994.
25. L inhibits ara-C-induced CPP32/yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res., 56: 4743-4748, 1996.
26. Powers, R. H., Stadnicka, A., Kalbfleish, J. H., and Skibba, J. L. Involvement of xanthine oxidase in oxidative stress and iron release during hyperthermic rat liver perfusion. Cancer Res., 52: 1699-1703, 1992.
27. Huang, R-P., Wu, J-X., Fan, Y., and Adamson, E. D. UV activates growth factor receptors via reactive oxygen intermediates. J. Cell Biol., 133: 211-220, 1996.
28. O'Dwyer, P. J., Yao, K-S., Ford, P., Godwin, A. K., and Clayton, M. Effects of hypoxia on detoxicating enzyme activity and expression in HT29 colon adenocarcinoma cells. Cancer Res., 54: 3082-3087, 1994.
29. Salnikow, K., Gao, M., Voitkun, V., Huang, X., and Costa, M. Altered oxidative stress response in nickel-resistant mammalian cells. Cancer Res., 54: 6407-6412, 1994.
30. Pieri, C., Recchioni, R., Marcheselli, F., Moroni, F., Marra, M., and Benatti, C. The impairment of mitochondrial membrane potential and mass in proliferating lymphocytes from vitamin E-deficient animals is recovered by glutathione. Cell. Mol. Biol., 41: 755-762, 1995.
31. Sohal, R. S., and Weindruch, R. Oxidative stress, caloric restriction, and aging. Science (Washington DC), 273: 59-63, 1996.
32. 2+ in toxic cell killing. Trends Pharmacol. Sci., 10: 281-285, 1989.
33. Chinnaiyan, A. M., and Dixit, V. M. The cell-death machine. Curr. Biol., 6: 555-562, 1996.
34. Bailey, H. H., Mulcahy, R. T., Tutsch, K. D., Arzoomanian, R. Z., Alberti, D., Tombes, M. B., Wilding, G., Pomplun, M., and Spriggs, D. R. Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione. J. Clin. Oncol., 12: 194-205, 1994.
35. O'Dwyer, P. J., Hamilton, T. C., LaCreta, F. P., Gallo, J. M., Kilpatrick, D., Halbherr, T., Brennan, J., Bookman, M. A., Hoffman, J., Young, R. C., Comis, R. L., and Ozols, R. F. Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer. J. Clin. Oncol., 14: 249-256, 1996.